Myocardial sulfhydryl (SH)-containing compounds, including reduced glutathione (GSH), are both defenses against and potential markers of reactive oxygen metabolite injury during ischemia and reperfusion. We examined the alterations in GSH and other myocardial SH pools during reperfusion in anesthetized dogs exposed to brief (15 minutes, n=7) or prolonged (90 minutes, n=6) regional ischemia caused by occlusion of the left anterior descending artery. Ninety minutes of ischemia followed by 5 hours of reperfusion, which resulted in myocardial necrosis of 43.9±4.0% of the area at risk, caused a 22% reduction in total myocardial SH groups (p<0.01), a 57% decrease in nonprotein myocardial SH groups (p<0.01), a 56% decrease in GSH (p<0.01), and a 62% decrease in non-GSH, nonprotein SH groups (p<0.02). However, protein SH groups were not significantly reduced (12% decrease, p=NS). Also, myocardial release of GSH and oxidized glutathione (GSSG) into the coronary venous effluent occurred during early reperfusion. In contrast, 15 minutes of ischemia, followed by 30 minutes of reperfusion, did not alter myocardial total SH groups, protein SH groups, or GSH (9% decrease, p=NS); nor was there reperfusion release of GSH or GSSG. However, even with brief ischemia, nonprotein SH groups decreased 23% (p<0.05), due mainly to a 59% decrease in the non-GSH, nonprotein SH pool (p<0.05). These changes after brief ischemia occurred without alterations in myocardial GSSG or the GSH/GSSG ratio. Thus, the pattern of depletion of myocardial SH pools during reperfusion differs depending on the duration of the preceding ischemia. The decreases in nonprotein SH and in non-GSH, nonprotein SH pools did not occur (9% decrease and 3% decrease, respectively; both p =NS) in dogs subjected to brief occlusion (n =6) that were treated before coronary occlusion with 500 mg/kg i.v. dimethylthiourea, an intracellular scavenger of H202 and *OH. Since only the non-GSH, nonprotein SH pool decreased significantly after brief ischemia and since this decrease could be prevented by antioxidant intervention, this pool appears to be the most sensitive SH indicator of reactive oxygen metabolite-induced myocardial ischemia/ reperfusion injury. (Circulation Research 1991:68:605-613) Reactive oxygen metabolites produced during myocardial ischemia and reperfusion appear to contribute to the postischemic myocardial contractile dysfunction ("stunning") caused by brief ischemia,l-3 as well as the myocardial necrosis following prolonged periods of ischemia. 
Reactive oxygen metabolites produced during myocardial ischemia and reperfusion appear to contribute to the postischemic myocardial contractile dysfunction ("stunning") caused by brief ischemia,l-3 as well as the myocardial necrosis following prolonged periods of ischemia.4-6 Myocardial sulfhydryl (SH) compounds are important during regional ischemia is unknown, since these previous studies using in vivo regional ischemia and reperfusion were limited to measurements of total glutathione levels in models of prolonged ischemia. We measured GSH and other myocardial SH pools to compare the relative changes in myocardial SH pools during in vivo regional ischemia and reperfusion. In addition, we compared the changes in SH pools that occurred in two models of ischemia/reperfusion injury: a "brief" 15-minute occlusion without myocardial necrosis and a "prolonged" 90-minute occlusion involving myocardial necrosis. Differential changes in SH pools in these two models could reflect different magnitudes of oxidative injury during reperfusion, perhaps influenced by the duration of the preceding ischemic insult. Furthermore, any SH pools that are reduced after brief ischemia should be sensitive SH indexes of ischemia/reperfusion injury.
Materials and Methods

Canine Model of Ischemia/Reperfusion
Mongrel dogs of either sex (18-27 kg) were anesthetized with thiamylal sodium (8 mg/kg) and chloralose (100 mg/kg), with supplemental chloralose given as needed. Dogs were intubated and ventilated with 35% 02-65% N2 to maintain arterial oxygenation in the physiological range at Denver's altitude. A left lateral thoracotomy was performed, and the heart was suspended in a pericardial cradle. Catheters were inserted into the distal aorta via the femoral artery and into the left atrium. The left anterior descending artery (LAD) was dissected free 2-3 cm distal to its origin, and a snare occluder was placed around it. In a subgroup of dogs, a 20-gauge angiocatheter was inserted into the coronary sinus with the tip at the orifice of the great cardiac vein to obtain venous blood from the LAD region. 10, 22 This allows sampling of blood from the ischemic/reperfused LAD zone, although there is some admixture from nonischemic myocardium.
LAD occlusion was performed by tightening the snare for either 15 minutes (brief occlusion)1-3 or 90 minutes (prolonged occlusion).4-6 All dogs developed a visible area of regional cyanosis and dyskinesis during LAD occlusion. Reperfusion was accomplished by release of the snare and resulted in transient ventricular tachycardia and resolution of cyanosis in all dogs. In dogs in which myocardial GSH and GSSG release was measured, regional myocardial blood flow was determined at 10 (brief) or 75 (prolonged) minutes of occlusion by the injection of 15 -,m-diameter radiolabeled microspheres. 23 Reperfusion was continued for 300 minutes in prolonged-occlusion dogs and for 30 minutes in briefocclusion dogs. Area at risk and infarct size were measured by a postmortem dual-perfusion method using Evans blue and triphenyl tetrazolium chloride.4
A separate group of dogs was used for tissue measurements. Transmural biopsies weighing 50-100 mg were obtained by use of a hollow biopsy drill (Alko Diagnostic Corp., Holliston, Mass.) with a 4-mm drill bit, as previously described.24 Biopsies are frozen within 2 seconds by this instrument, which immerses the biopsy in isopentane (-150°C) cooled by a liquid nitrogen jacket. All biopsies obtained at the end of reperfusion were taken within 2 minutes, while arterial blood pressure and oxygenation were maintained. Biopsies obtained sequentially during the experiment were closed by purse-string epicardial sutures using pledgets. All LAD region biopsies were obtained in a region of the heart located between the LAD and one of its diagonal branches from myocardium that visually appeared dyskinetic. We used transmural biopsies so that we could use a rapidfreezing technique that minimizes the SH group oxidation that has hampered measurements of these groups in previous studies. 20 Tissue was stored at -70°C until analysis.
Infarct size was determined in the 90-minuteocclusion dogs, which were reperfused for 5 hours, by incubation with triphenyl tetrazolium chloride. Risk area could not be determined by the dual perfusion method because of biopsy wounds in the myocardium; therefore, it was determined by injection of technetium-99m-radiolabeled 15 -,m albumin microspheres (3M Co., Minneapolis, Minn.) at 75 minutes of occlusion, followed by subsequent autoradiography.5,25,26 Because of the need for rapid sample processing to prevent SH group oxidation, we were not able to obtain both tissue biopsy and coronary sinus samples simultaneously in the same dogs during early reperfusion. In the 15-minute-occlusion dogs, the absence of myocardial infarcts in all dogs was confirmed by tetrazolium staining; risk area was not measured because of biopsy wounds in the myocardium. A reduction in tissue ATP, previously described in this model,27 was used to confirm that LAD zone ischemia occurred during coronary occlusion. Six dogs received therapy before 15 minutes of ischemia with dimethylthiourea (DMTU) (500 mg i.v. in 500 ml normal saline over one-half hour) to test if SH group changes were reduced when a reactive oxygen metabolite scavenger was given.25 Three additional dogs underwent 90 minutes of sham LAD coronary "occlusion" followed by S hours of "reperfusion" as time controls.
Measurement of Coronary Sinus GSH and GSSG Release
Samples were obtained and processed as we have previously described.10 Coronary sinus and paired aortic samples were obtained before the occlusion, at the end of the occlusion period, and at 2, 5, 7, 10, 15, and 30 minutes of reperfusion. One-milliliter blood samples were obtained simultaneously from arterial and coronary sinus catheters and then immediately divided (0.5 ml each) into separate tubes containing GSH and GSSG collection buffer. GSH collection buffer consisted of 0.5 ml of 0.1 M potassium phosphate buffer, pH 7.4, containing 3 mM dinitrothiobenzene (DTNB) and 5 mM EDTA. Superna-tants for GSH assay were frozen at -70C until analysis. GSSG collection buffer was 0.3 ml of 0.1 M potassium phosphate buffer at pH 6.5 with 10 mM N-ethylmaleimide (NEM) and 5 mM EDTA. NEM reacts with reduced SH groups and prevents their detection in the assay. Supernatants for GSSG analysis were then processed to remove unreacted NEM. Supernatants (0.4 ml) were passed through Sep-Pak C18 cartridges (Waters Associates, Milford, Mass.), followed by 1 ml potassium phosphate buffer. The eluate was frozen and stored at -70°C until analysis.
An adaptation of the assay'0 devised by Tietze28 and modified by Adams et a129 was used to measure GSH and GSSG using a multiwell plate-reader (Biotek, Highland Park, Vt.). For GSH assay, each well contained 50 ,ul of 5 mM EDTA and 3 mM DTNB in 0.1 mM potassium phosphate buffer, 10 ,u glutathione reductase (0.25 mg/ml, Sigma type III), 50 gul sample, and 100 ,ul potassium phosphate buffer.
For GSSG assay, reactants were similar, except 150 gl sample was used and the 100 gl potassium phosphate was omitted. Standard curves were used with concentrations of 0-500 pmol/well of both GSH and GSSG. Grossly hemolyzed samples occurred rarely (< 1%) and were discarded. The recovery of added GSH (10-100 nmol/ml) and GSSG (0.5-5 nmol/ml) averaged 93% and 96%, respectively. Less than 0.4% of added GSH was oxidized to GSSG during processing.
Measurement of Myocardial GSH and GSSG
Analyses were performed by the method of Ishikawa and Sies.30 Approximately 100 mg tissue for GSH assay was pulverized at liquid nitrogen temperature, weighed, and homogenized at 4°C in 6 vol of 1 M perchloric acid with 2 mM EDTA. The homogenate was centrifuged, and the supernatant was neutralized to pH 7.0 with 2 M KOH in 0.3 M MOPS. The supernatant was then recentrifuged, and the resulting supernatant was assayed by the plate-reader method described above. Tissue for GSSG analysis was homogenized in 6 vol of 1 M perchloric acid with 2 mM EDTA and 10 mM NEM. The supernatant was neutralized to pH 6.2 by 2 M KOH and 0.3 M MOPS.
One milliliter was applied to a previously unused Sep-Pak C18 column to extract unreacted NEM. An additional 1.0 ml of 0.1 M potassium phosphate eluted the sample. The combined eluate was used for GSSG assay using the glutathione reductase assay described above. The recovery of added GSH averaged 89%, and recovery of added GSSG averaged 85%. DMTU did not alter measured GSH levels, although it interfered with measurement of GSSG, probably by an effect on the Sep-Pak columns.
Measurement of Myocardial Total SH and Nonprotein SH Groups
Myocardial SH groups were determined by a modification of the method of Sedlak and Lindsay,31 which uses the spectrophotometric end point of the reaction of SH groups with DTNB. Approximately 100 mg tissue was homogenized in 2 ml of 0.02 M EDTA at 4°C. For assay of total SH groups, 125 ,ul supernatant was combined with 375 gl of 0.2 M Tris, pH 8.2; 25 gl of 0.01 M DTNB in methanol; and 1,975 ,ul methanol. The methanol is used as a protein-denaturing agent. The reaction was allowed to stand for 15 minutes; samples were then centrifuged at 3,000g for 15 minutes, and OD412 of the supernatant was measured. A molar absorbance of 13,100 cm-1 mol-1 was used to calculate SH group concentration. Nonprotein SH groups were measured using 1,250 ul original supernatant. To this, 1 ml deionized water and 250 gl of 50% trichloroacetic acid, to precipitate proteins, was added. The tube was agitated, allowed to stand for 15 minutes, and centrifuged for 15 minutes at 3,000g. Five hundred microliters of the resulting supernatant was added to 1 ml of 0.4 M Tris, pH 8.9, and 0.1 M DTNB in phosphate buffer. The mixture was agitated, OD412 was measured, and the extinction coefficient was used to determine SH group concentration. GSH was used as the SH group standard. Protein SH groups were calculated as the difference between total and nonprotein SH levels. Non-GSH, nonprotein SH groups were calculated as the difference between nonprotein SH and GSH. DMTU did not alter SH levels measured by these assays. Tissue GSH and GSSG were measured in the ischemic/reperfused LAD zone and the normal circumflex (LCX) zone. Tissue GSH was markedly reduced in the LAD region compared with the LCX region at 300 minutes of reperfusion ( Figure 1 , top panels). Tissue GSSG was similar in both regions (LAD, 18.4-+1.3 nmol/g tissue; LCX, 21.9+1.8 nmol/g tissue; n= 12, p=NS). The GSH/GSSG ratio, an index of myocardial oxidative stress,3035 was reduced in the LAD zone ( Figure 1 (Figure 2 ).
As previously described,'1 prolonged coronary occlusion caused release of GSH and GSSG into the coronary sinus during early reperfusion. Levels in the coronary sinus were elevated compared with corresponding levels in the aorta, as well as compared with preocclusion coronary sinus levels ( Figures 3 and 4 , left panels). This release of GSH coincides with the decrease in myocardial GSH seen at end occlusion and during reperfusion (Figure 2 Total tissue SH groups were decreased in the LAD region compared with the LCX zone when measured at 300 minutes of reperfusion (n-6,p<0.01) ( Figure  5 ). This was due mainly to a decrease in the nonprotein SH groups (p<0.01), which include GSH. The fall in the nonprotein SH pool was due to significant decreases in both GSH and non-GSH, nonprotein SH groups (p<0.02). There was a modest trend toward a decrease in protein SH groups, but this did not reach significance (p=0.20) (Figure 5 (Figures 3 and 4 , right panels). Plasma levels of GSH and GSSG measured in the coronary sinus in the brief-occlusion dogs were similar to levels in the aorta. LAD regional myocardial blood flow during occlusion was similar in the prolonged-occlusion dogs (endocardium, 0.16±0.07 ml/min/g; epicardium 0.33+0.08 ml/min/g; n=5) and brief-occlusion dogs (endocardium, 0.14±0.08 ml/ min/g; epicardium, 0.25 -t-0.04 ml/min/g; n =5, p =NS).
Total SH and protein SH groups were similar in LAD and LCX regions in the brief-occlusion model ( Figure 6 ). However, nonprotein SH groups in the LAD region were decreased compared with the LCX zone ( Figure 6 ). This was due to a significant decrease in the non-GSH, nonprotein SH pool ( Figure  6 ) while GSH was unchanged. Therefore, although most SH groups are preserved, even with brief coronary occlusions there is a selective decrease in low molecular weight SH compounds other than GSH.
ATP was reduced in transmural biopsies from the LAD region (4.3+0.5 amol/g, n=7) compared with LCX (6.0±0.4 gmol/g, n=7; p=0.05) ( Table 2 ). The GSH NON-PROTEIN SH decrease of 23% in transmural ATP is similar to changes previously reported with 15 minutes of regional ischemia followed by reperfusion. 27 Six additional dogs were treated with DMTU (500 mg/kg i.v. over 20 minutes) before 15 minutes of occlusion and 30 minutes of reperfusion to test whether the decrease in non-GSH, nonprotein SH could be reduced by therapy with a scavenger of reactive oxygen metabolites. DMTU was chosen since it is a cell-permeable scavenger of H202 and .OH that reduced canine myocardial injury after both brief2 and prolonged5 periods of ischemia. ATP decreased by 28% in the LAD region (Table 2) , similar to the decrease in untreated controls. Total SH and protein SH were unchanged after ischemia and reperfusion (Table 2) . GSH decreased 11% (p=NS), similar to the decrease in untreated animals. DMTU reduced the decrease in nonprotein (9% decrease) and non-GSH, nonprotein SH pools (3% decrease) that occurred in untreated controls (Table 2) . Thus, these two sensitive SH pools were protected by a cell-permeable scavernger of H202 and .OH. Heart rate-blood pressure product, heart rate, and aortic pressure were unchanged during ischemia and reperfusion and were not significantly different from the other groups. 
Tissue SH Groups in Time Controls
Tissue SH groups at the end of the reperfusion period were similar in time controls and the normal LCX zone in the 90-minute occlusion model (Table  3) . Tissue GSSG at the end of reperfusion was also similar to the GSSG levels measured throughout reperfusion in the 90-minute occlusion model. Discussion Reactive oxygen metabolites appear to contribute to in vivo myocardial ischemia/reperfusion injury.1-6 Support for this concept is predominantly based on experiments in which oxygen metabolite scavengers reduce evidence of myocardial injury in brief (15-minute) and prolonged (90-minute) models of coronary occlusion. The prolonged occlusion model involves myocardial necrosis4-6; the brief occlusion model does not.1-3 Superoxide dismutase (a scavenger of superoxide anion),"4 DMTU (a scavenger of hydrogen peroxide and the hydroxyl radical),2,5 and deferoxamine (a blocker of iron-catalyzed hydroxyl generation)3'6 reduce injury in both models. Despite apparent reductions in infarct size measured at 6 hours of reperfusion or improved recovery of regional function with scavenger treatment, there is little insight into the oxidative alterations that occur with these two differing degrees of ischemia/reperfusion injury.
We found that during reperfusion after a 90-minute coronary occlusion there was a decrease in myocardial total SH levels. This decrease in SH groups involved mainly nonprotein SH groups, in- cluding both GSH and the non-GSH, nonprotein pool. Protein SH groups were relatively well preserved, even with this severe ischemic insult. Decreases in most SH pools with release of GSSG from myocardium are consistent with substantial oxidative injury in the prolonged occlusion model. In contrast, brief periods of ischemia, although similar with respect to the degree of blood flow reduction, are not associated with such striking changes in SH groups. Myocardial tissue levels of GSH, GSSG, total, and protein SH groups were unchanged. However, even this brief period of ischemia followed by reperfusion caused a significant decrease in the nonprotein SH pool, due to a fall in non-GSH, nonprotein SH groups.
The non-GSH, nonprotein SH pool may be a sensitive marker of the injury that occurs with brief occlusions. This pool is composed of the SH-containing amino acid cysteine, its derivatives such as cysteamine, and other low molecular weight SH groups. These include acetyl coenzyme A, ergothioneine, and lipoic acid.36 Ergothioneine is a naturally occurring dietary SH molecule that is present in animal tissues. 36 Most animal tissues, including heart, have a total non-GSH, nonprotein SH level of 0.3-0.7 ,umol/g tissue,36 which is in excellent agreement with the myocardial levels we obtained in the normal region. The decrease in the non-GSH, nonprotein SH pool in the brief model occurred while myocardial GSH, GSSG, and other SH pools were unchanged. The decrease was prevented by treatment with DMTU, an intracellular scavenger of H202 and .OH, further suggesting that the decrease is due to alterations induced by reactive oxygen metabolites. The decrease in non-GSH, nonprotein SH groups appears to be a sensitive indicator of mild oxidative injury. Mild oxidative injury probably decreases the non-GSH, nonprotein SH pool before GSH or GSSG are changed because, although glutathione reductase reduces GSSG to GSH, it cannot reduce the oxidized forms of non-GSH, nonprotein SH groups. 28 Canine myocardial ischemia longer than 45 minutes is associated with myocyte membrane disruption in the ischemic zone. 37 Since GSH is normally secreted only by the liver,7 the myocardial GSH release during reperfusion after 90 minutes of ischemia probably requires severe membrane injury. 
